IRWD
Ironwood Pharmaceuticals, Inc. · Healthcare
CMO,SVP,Head-Res, Drug Michael Shetzline sold $219K of Ironwood Pharmaceuticals, Inc.
Sold$219,479
$11.36Price
19,322Shares
−7%Stake
What IRWD did after the filing
- The stock from Wed, Mar 1 close, $11.39
- −2.5%
- S&P 500, same days
- +5.1%
Measured over 30 trading days, to the Apr 13 close.
Traded Mon, Feb 27. Filed Wed, Mar 1, 1:21 PM ET, during the session. Returns use the Mar 1 close and the Apr 13 close. Not investment advice.